Literature DB >> 18684815

Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA.

Kenji Takeuchi1, Takayuki Komatsu, Yoshinori Kitagawa, Kiyonao Sada, Bin Gotoh.   

Abstract

Sendai virus (SeV) C protein is a multifunctional protein that plays important roles in regulating viral genome replication and transcription, antagonizing the host interferon system, suppressing virus-induced apoptosis, and facilitating virus assembly and budding. We here report a novel role of SeV C protein, the limitation of double-stranded RNA (dsRNA) generation for maintaining the rate of protein synthesis in infected cells. It was found that the intracellular protein synthesis rate was maintained even after wild-type (wt) SeV infection, but markedly suppressed following C-knockout SeV infection. This indicates the requirement of C protein for maintaining protein synthesis after infection. In contrast to wt SeV infection, C-knockout SeV infection caused phosphorylation of both the translation initiation factor eIF2alpha and dsRNA-dependent protein kinase (PKR). Phosphorylation of eIF2alpha occurred mainly due to the action of PKR, since knockdown of PKR by small interfering RNA limited eIF2alpha phosphorylation. C protein, however, could inhibit neither poly(I):poly(C)-activated nor Newcastle disease virus-induced phosphorylation of PKR and eIF2alpha, suggesting that C protein does not target common pathways leading to PKR activation. Immunofluorescent staining experiments with a monoclonal antibody specifically recognizing dsRNA revealed generation of a large amount of dsRNA in cells infected with C-knockout SeV but not wt SeV. The dsRNA generation as well as phosphorylation of PKR and eIF2alpha induced by C-knockout SeV was markedly suppressed in cells constitutively expressing C protein. Taken together, these results demonstrate that the SeV C protein limits generation of dsRNA, thereby keeping PKR inactive to maintain intracellular protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684815      PMCID: PMC2566265          DOI: 10.1128/JVI.00599-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role.

Authors:  M K Hasan; A Kato; M Muranaka; R Yamaguchi; Y Sakai; I Hatano; M Tashiro; Y Nagai
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity.

Authors:  K Kiyotani; S Takao; T Sakaguchi; T Yoshida
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

3.  Monoclonal antibodies to double-stranded RNA as probes of RNA structure in crude nucleic acid extracts.

Authors:  J Schönborn; J Oberstrass; E Breyel; J Tittgen; J Schumacher; N Lukacs
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

4.  The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus.

Authors:  C Orvell; M Grandien
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  The characteristics required for a Sendai virus preparation to induce high levels of interferon in human lymphoblastoid cells.

Authors:  M D Johnston
Journal:  J Gen Virol       Date:  1981-09       Impact factor: 3.891

6.  The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling.

Authors:  Bin Gotoh; Kenji Takeuchi; Takayuki Komatsu; Junko Yokoo
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site.

Authors:  Bin Gotoh; Takayuki Komatsu; Kenji Takeuchi; Junko Yokoo
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

8.  Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons.

Authors:  J Miyakoshi; K D Dobler; J Allalunis-Turner; J D McKean; K Petruk; P B Allen; K N Aronyk; B Weir; D Huyser-Wierenga; D Fulton
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

9.  C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production.

Authors:  Takayuki Komatsu; Kenji Takeuchi; Junko Yokoo; Bin Gotoh
Journal:  Virology       Date:  2004-07-20       Impact factor: 3.616

10.  The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing.

Authors:  J Curran; R Boeck; D Kolakofsky
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  56 in total

1.  Measles virus C protein interferes with Beta interferon transcription in the nucleus.

Authors:  Konstantin M J Sparrer; Christian K Pfaller; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA.

Authors:  Maria Teresa Sánchez-Aparicio; Dominique Garcin; Charles M Rice; Daniel Kolakofsky; Adolfo García-Sastre; Alina Baum
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

3.  Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein.

Authors:  Takashi Irie; Katsuhiro Kiyotani; Tomoki Igarashi; Asuka Yoshida; Takemasa Sakaguchi
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 4.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 5.  Interplay between innate immunity and negative-strand RNA viruses: towards a rational model.

Authors:  Denis Gerlier; Douglas S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2011-09       Impact factor: 11.056

6.  Measles Virus Defective Interfering RNAs Are Generated Frequently and Early in the Absence of C Protein and Can Be Destabilized by Adenosine Deaminase Acting on RNA-1-Like Hypermutations.

Authors:  Christian K Pfaller; George M Mastorakos; William E Matchett; Xiao Ma; Charles E Samuel; Roberto Cattaneo
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

7.  Stress Granules and Virus Replication.

Authors:  Cathy L Miller
Journal:  Future Virol       Date:  2011       Impact factor: 1.831

8.  Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA.

Authors:  Ruoxing Wang; Jundi Wang; Amber M Paul; Dhiraj Acharya; Fengwei Bai; Faqing Huang; Yan-Lin Guo
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

9.  Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

Authors:  Takashi Irie; Natsuko Nagata; Tomoki Igarashi; Isao Okamoto; Takemasa Sakaguchi
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

10.  Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.

Authors:  Grégory Caignard; Anastassia V Komarova; Mehdi Bouraï; Thomas Mourez; Yves Jacob; Louis M Jones; Flore Rozenberg; Astrid Vabret; François Freymuth; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.